Symptomatic improvement in patients treated with intermittent infusion of inotropes: A double-blind placebo controled pilot study

Journal of Medicine

Volumn 33, Issue 1-4, 2002, Pages 129-146

  López Candales, Angel ^a   Vora, Tushar ^c   Gibbons, William ^b   Carron, Christine ^c   Simmons, Paula ^c   Schwartz, Jeffrey ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c S560 Scaife Hall ^*

Author keywords

And six minute walk test; Angiotensin converting enzyme; Cardiomyopathy; Echocardiography; Heart failure; Inotropes; Left ventricular function; Mitral insufficiency; Quality of life scores

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; HYDRALAZINE; INOTROPIC AGENT; MILRINONE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE CALCULATION; DOSE RESPONSE; DRUG INFUSION; DRUG SAFETY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EMERGENCY WARD; EXERCISE TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE PRESSURE; HUMAN; INOTROPISM; MALE; MITRAL VALVE REGURGITATION; OUTPATIENT CARE; PHYSICAL EXAMINATION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME;

AGED; CARDIOTONIC AGENTS; CROSS-OVER STUDIES; DOBUTAMINE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MILRINONE; PILOT PROJECTS; QUALITY OF LIFE; TIME FACTORS;

EID: 18744425716     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Agency for Health Care Policy and Research, Public Health service, U.S. Department of Health and Human Services, June 1994.
2. Bittner, V., Weiner, D.H., Yusuf, S., Rogers, W.J., McIntyre, K.M., Bangdiwala, S.I., Kronenberg, M.W., Kostis, J.B., Kohn, R.M., Guillotte, M., Greenberg, B., Woods, P.A. and Bourassa, M.G. (1993).: Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 270: 1702-1707.
3. Brunner-La Rocca, H.P., Vaddadi, G. and Esler MD. (1999): Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism. J Am Coll Cardiol. 33: 1163-1173.
4. Canver, C.C. and Chanda, J. (2000).: Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates. Ann Thorac Surg. 69: 1823-1826.
5. Cesario, D., Clark, J. and Maisel, A. (1998): Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. Am Heart J. 135: 121-129.
6. Cusick, D.A., Pfeifer, P.B. and Quigg, R.J. (1998): Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and re-hospitalization rates in patients with severe heart failure. Am J Cardiol. 82: 1060-1065.
7. De Marco, T. and Chatterjee, K. (1996): Refractory heart failure: a therapeutic approach. J Intensive Care Med. 11: 121-148.
8. Felker, G.M. and O'Connor, C.M. (2001): Inotropic therapy for heart failure: an evidence-based approach. Am Heart J. 142: 393-401.
9. Hunt, S.A., Baker, D.W., Chin, M.H., Cinquegrani, M.P., Feldman, A.M., Francis, G.S., Ganiats, T.G., Goldstein, S., Gregoratos, G., Jessup, M.L., Noble, R.J., Packer, M., Silver, M.A., Stevenson, L.W., Gibbons, R.J., Antman, E.M., Alpert, J.S., Faxon, D.P., Fuster, V., Jacobs, A.K., Hiratzka, L.F., Russell, R.O., Smith, S.C. Jr. and American College of Cardiology/American Heart Association. (2001): ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 38: 2101-2113.
10. Hatzizacharias, A., Makris, T., Krespi, P., Triposkiadis, F., Voyatzi, P., Dalianis, N. and Kyriakidis, M. (1999): Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure. Am Heart J. 138: 241-246.
11. Heart Failure: management of patients with left-ventricular systolic dysfunction. Quick reference guide for clinicians. no 11. AHCPR Publication No. 94-0613. Rockville (MD):
12. Jensen-Urstad, K., Bouvier, F., Hojer, J. (1998): Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. Am J Cardiol. 81: 538-544.
13. Kannel, W.B. and Belenger, A.J. (1991): Epidemiology in heart failure. Am Heart J. 121:951-957.
14. Leier, C.V. and Binkley, P.F. (1998): Parenteral inotropic support for advanced congestive heart failure. Progress in Cardiovasc Diseases 41: 207-224.
15. Lipkin, D.P., Scriven, A.J., Crake, T. and Poole-Wilson, P.A. (1986): Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J. 292: 653-655.
16. López-Candales, A., Carron, C., Graham, S. and Schwartz, J. (2000): Intermittent infusion of inotropes in the outpatient setting: one-year post treatment analysis. Puerto Rico Health Science Journal 19: 107-114.
17. López-Candales, A., Carron, C., Graham, S. and Schwartz, J. (2001): Outpatient cardiac infusion units: impact in elderly patients with refractory heart failure. American Journal of Geriatric Cardiology 10: 188-192.
18. Marius-Nunez, A.L., Heaney, L., Fernandez, R.N., Clark, W.A., Ranganini, A., Silber, E. and Denes, P. (1996): Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. Am Heart J. 132: 805-808.
19. O'Connell, J.B. and Bristow, M.R. (1994): Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 13: S107-112.
20. Otto, C. In: Textbook of Clinical Echocardiography. Edited by Pearlman, S., Saunders, Philadelphia, 1995.
21. Oxman, T.E. and Hull, J.G. (2001): Social support and treatment response in older depressed primary care patients. J Gerontol B Psychol Sci Soc Sci. 56: P35-45.
22. Packer, M., Coats, A.J., Fowler, M.B., Katus, H.A., Krum, H., Mohacsi, P., Rouleau, J.L., Tendera, M., Castaigne, A., Roecker, E.B., Schultz, M.K. and DeMets, D.L. (2001): Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 344: 1651-1658.
23. Packer, M. (2001): Current role of beta-adrenergic blockers in the management of chronic heart failure. Am J Med. 110 Suppl 7A: 81S-94S.
24. Rector, T.S. and Cohn, J.N. (1992): Assessment of patient outcome with the Minnesota Living With Heart Failure questionnaire: reliability and validity during a randomized, double-blind placebo-controlled trial of pimobendan. Am Heart J. 124: 1017-1025.
25. Rector, T.S., Kubo, S.H. and Cohn, J.N. (1993): Validity of the Minnesota Living With Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 71: 1106-1107.
26. Schiller, N.B., Shah, P.M. and Crawford, M. (1989): Recommendations foe quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2: 358-367.
27. Shibata, M.C., Flather, M.D. and Wang, D. (2001): Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail. 3: 351-357.
28. Smith, W.H. and Ball, S.G. (2000): ACE inhibitors in heart failure: an update. Basic Res Cardiol. 95: Suppl 1: I8-14.
29. Starling, R.C. (1998): The heart failure pandemic. Changing patterns, costs, and treatment strategies. Cleveland Clinic J Med. 65: 351-358.
30. The Beta-Blocker Evaluation of Survival Trial Investigators. (2001): A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 344: 1659-1667.
31. Vaccarino, V., Kasl, S.V., Abramson, J. and Krumholz, H.M. (2001): Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 38: 199-205.
32. Vitarelli, A. and Gheorghiade, M. (2000): Transthoracic and transesophageal echocardiography in the hemodynamic assessment of patients with congestive heart failure. Am J Cardiol. 86: 36G-40G.
33. Weinberger, M., Oddone, E.Z. and Henderson, W.G. (1996): Does increased access to primary care reduces hospital re-admissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Re-admissions. New Engl J Med. 334: 1441-1447.
34. Wolinski, F.D., Overhage, J.M., Stump, T.E., Lubitz, R.M. and Smith, D.M. (1997): The risk of hospitalization for congestive heart failure among older adults. Med Care 35: 1031-1043.
35. Woods, T.D. and Prisant, L.M. (2000): Pulsed inotropic therapy in chronic congestive heart failure: a review of the literature. Am J Ther. 7: 375-380.
36. Yock, P.G. and Popp, R.L. (1984): Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70: 657-662.
37. Young, J.B. and Moen, E.K. (2000): Outpatient parenteral inotropic therapy for advanced heart failure. J Heart Lung Transplant 19: S49-57.
38. Yusuf, S., Thom, T. and Abbot, R.D. (1989): Changes in hypertension treatment and in congestive heart failure mortality. Hypertension 1989; 13(5 Suppl): I74-179